This page lists the SEC filings reported by ACP IV, L.P..
| Type | Filed | Filer | Subject | Shares Owned | Percent Owned | |
|---|---|---|---|---|---|---|
| SC 13D/A | 2016-06-24 | ACP IV, L.P. | Carbylan Therapeutics, Inc. | 4,343,550 | 16.5% | EDGAR |
| SC 13D/A | 2015-06-17 | ACP IV, L.P. | ACELRX PHARMACEUTICALS INC | 2,178,399 | 4.9% | EDGAR |
| SC 13D | 2015-04-24 | ACP IV, L.P. | Carbylan Therapeutics, Inc. | 4,343,550 | 16.6% | EDGAR |
| SC 13D/A | 2014-07-18 | ACP IV, L.P. | AERIE PHARMACEUTICALS INC | 989,582 | 4.2% | EDGAR |
| SC 13D/A | 2014-05-30 | ACP IV, L.P. | AERIE PHARMACEUTICALS INC | 3,989,582 | 16.8% | EDGAR |
| SC 13D | 2013-11-12 | ACP IV, L.P. | AERIE PHARMACEUTICALS INC | 4,289,582 | 19.3% | EDGAR |
| SC 13D/A | 2012-12-18 | ACP IV, L.P. | ACELRX PHARMACEUTICALS INC | 2,794,907 | 7.5% | EDGAR |
| SC 13D | 2011-02-28 | ACP IV, L.P. | ACELRX PHARMACEUTICALS INC | 2,794,907 | 14.4% | EDGAR |
- Form 13F-HR
- The 13F-HR report is filed quarterly to report securities held by the filer that fall under the SEC's 13F rules.
- Form SC 13D/G
- Reported by persons and groups who own 5% or more of any class of a company's outstanding shares. If the ownership changes by 1% or more, an amendment must be filed.
- Form 3, 4, and 5
- Form 3, 4, and 5 reports are filed to report insider transactions by company officers and directors, and any beneficial owners of more than ten percent of a company's shares. Form 3 is the initial report that must be filed when a person becomes an officer, director, or beneficial owner. Form 4 reports are used to report changes in ownership, while the Form 5 report is used for reporting transactions that should have been reported earlier in a Form 4 filing.